Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 277

1.

Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups.

Macchia G, Cerrotta A, Deodato F, Pappalardi B, Santoni R, Campitelli M, Scambia G, Valentini V, Aristei C, Ferrandina G.

Crit Rev Oncol Hematol. 2020 Mar 3;149:102925. doi: 10.1016/j.critrevonc.2020.102925. [Epub ahead of print] Review.

PMID:
32200268
2.

A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.

Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D'Agostino GR, Deodato F, Maranzano E, Ippolito E, Ronchi S, Paiar F, Scorsetti M, Cilla S, Ingargiola R, Huscher A, Cerrotta AM, Fodor A, Vicenzi L, Russo D, Borghesi S, Perrucci E, Pignata S, Aristei C, Morganti AG, Scambia G, Valentini V, Jereczek-Fossa BA, Ferrandina G.

Oncologist. 2020 Feb;25(2):e311-e320. doi: 10.1634/theoncologist.2019-0309. Epub 2019 Oct 10.

3.

Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors.

Buwenge M, Scirocco E, Deodato F, Macchia G, Ntreta M, Bisello S, Siepe G, Cilla S, Alitto AR, Valentini V, Strigari L, Morganti AG, Cammelli S.

BMC Cancer. 2020 Feb 3;20(1):90. doi: 10.1186/s12885-020-6581-5.

4.

Template-based automation of treatment planning in advanced radiotherapy: a comprehensive dosimetric and clinical evaluation.

Cilla S, Ianiro A, Romano C, Deodato F, Macchia G, Buwenge M, Dinapoli N, Boldrini L, Morganti AG, Valentini V.

Sci Rep. 2020 Jan 16;10(1):423. doi: 10.1038/s41598-019-56966-y.

5.

The Interaction between Amyloid Prefibrillar Oligomers of Salmon Calcitonin and a Lipid-Raft Model: Molecular Mechanisms Leading to Membrane Damage, Ca2+-Influx and Neurotoxicity.

Diociaiuti M, Bombelli C, Zanetti-Polzi L, Belfiore M, Fioravanti R, Macchia G, Giordani C.

Biomolecules. 2019 Dec 29;10(1). pii: E58. doi: 10.3390/biom10010058.

6.

Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1).

Arcelli A, Guido A, Buwenge M, Simoni N, Mazzarotto R, Macchia G, Deodato F, Cilla S, Bonomo P, Scotti V, Belgioia L, Tolento G, Cellini F, Grassi E, DI Marco M, Casadei R, Morganti AG, Cammelli S.

Anticancer Res. 2020 Jan;40(1):465-472. doi: 10.21873/anticanres.13975.

PMID:
31892602
7.

Radiotherapy Plus GnRH Analogue Versus High Dose Bicalutamide: A Case Control Study.

Buwenge M, Deodato F, Macchia G, Siepe G, Zhao X, Valicenti RK, Cilla S, Alitto AR, Ntreta M, Bisello S, Mantini G, Valentini V, Morganti AG, Cammelli S.

Anticancer Res. 2019 Nov;39(11):6373-6378. doi: 10.21873/anticanres.13850.

PMID:
31704870
8.

A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.

Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D'Agostino GR, Deodato F, Maranzano E, Ippolito E, Ronchi S, Paiar F, Scorsetti M, Cilla S, Ingargiola R, Huscher A, Cerrotta AM, Fodor A, Vicenzi L, Russo D, Borghesi S, Perrucci E, Pignata S, Aristei C, Morganti AG, Scambia G, Valentini V, Jereczek-Fossa BA, Ferrandina G.

Oncologist. 2019 Oct 10. pii: theoncologist.2019-0309. doi: 10.1634/theoncologist.2019-0309. [Epub ahead of print]

9.

Accelerated Middle Half Body Radiotherapy in Bone Metastases from Prostate Cancer: A Phase I Study (SHARON Project).

Zamagni A, Buwenge M, Macchia G, Siepe G, Cilla S, Cellini F, Arcelli A, Farina E, Deodato F, Cammelli S, Morganti AG.

Anticancer Res. 2019 Sep;39(9):5065-5069. doi: 10.21873/anticanres.13699.

PMID:
31519616
10.

Concurrent chromothripsis events in a case of TP53 depleted acute myeloid leukemia with myelodysplasia-related changes.

Tolomeo D, L'Abbate A, Lonoce A, D'Addabbo P, Miccoli MF, Lo Cunsolo C, Iuzzolino P, Palumbo O, Carella M, Racanelli V, Mazza T, Ottaviani E, Martinelli G, Macchia G, Storlazzi CT.

Cancer Genet. 2019 Sep;237:63-68. doi: 10.1016/j.cancergen.2019.06.009. Epub 2019 Jun 12.

PMID:
31447067
11.

Palliative Short-course Radiotherapy in Advanced Pelvic Cancer: A Phase II Study (SHARON Project).

Farina E, Macchia G, Siepe G, Zamagni A, Buwenge M, Scirocco E, Cellini F, Deressa BT, Tigeneh W, Uddin KAFM, Sumon MA, Caravatta L, Genovesi D, Mauro FA, Cammelli S, Cilla S, Morganti AG, Deodato F.

Anticancer Res. 2019 Aug;39(8):4237-4242. doi: 10.21873/anticanres.13585.

PMID:
31366511
12.

Definition of fields margins for the optimized 2D radiotherapy of prostate carcinoma.

Buwenge M, Perrone M, Siepe G, Capocaccia I, Woldemariam AA, Wondemagegnhu T, Uddin KAFM, Sumon MA, Galofaro E, Macchia G, Deodato F, Cilla S, Morganti AG.

Mol Clin Oncol. 2019 Jul;11(1):37-42. doi: 10.3892/mco.2019.1855. Epub 2019 May 8.

13.

Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival.

Morganti AG, Cellini F, Buwenge M, Arcelli A, Alfieri S, Calvo FA, Casadei R, Cilla S, Deodato F, Di Gioia G, Di Marco M, Fuccio L, Bertini F, Guido A, Herman JM, Macchia G, Maidment BW 3rd, Miller RC, Minni F, Passoni P, Valentini C, Re A, Regine WF, Reni M, Falconi M, Valentini V, Mattiucci GC.

BMC Cancer. 2019 Jun 11;19(1):569. doi: 10.1186/s12885-019-5790-2.

14.

Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.

Bisello S, Buwenge M, Palloni A, Autorino R, Cellini F, Macchia G, Deodato F, Cilla S, Brandi G, Tagliaferri L, Cammelli S, Valentini V, Morganti AG, Mattiucci GC.

Anticancer Res. 2019 Jun;39(6):3095-3100. doi: 10.21873/anticanres.13445.

PMID:
31177154
15.

Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study.

Ciabatti S, Ntreta M, Buwenge M, Gaudiano C, Sessagesimi E, Romani F, Angelini AL, Cammelli S, Macchia G, Deodato F, Zamagni A, Golfieri R, Morganti AG, Cilla S.

Med Dosim. 2019 Winter;44(4):356-364. doi: 10.1016/j.meddos.2019.01.008. Epub 2019 Apr 5.

PMID:
30955990
16.

Calcitonin native prefibrillar oligomers but not monomers induce membrane damage that triggers NMDA-mediated Ca2+-influx, LTP impairment and neurotoxicity.

Belfiore M, Cariati I, Matteucci A, Gaddini L, Macchia G, Fioravanti R, Frank C, Tancredi V, D'Arcangelo G, Diociaiuti M.

Sci Rep. 2019 Mar 26;9(1):5144. doi: 10.1038/s41598-019-41462-0.

17.

Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis.

Arcelli A, Buwenge M, Macchia G, Cammelli S, Deodato F, Cilla S, Galuppi A, Panni V, Mattiucci GC, Tagliaferri L, Morganti AG.

J Contemp Brachytherapy. 2019 Feb;11(1):21-27. doi: 10.5114/jcb.2019.82804. Epub 2019 Feb 28.

18.

Epid-based in vivo dose verification for lung stereotactic treatments delivered with multiple breath-hold segmented volumetric modulated arc therapy.

Cilla S, Ianiro A, Craus M, Viola P, Deodato F, Macchia G, Buwenge M, Morganti AG, Valentini V, Piermattei A.

J Appl Clin Med Phys. 2019 Mar;20(3):37-44. doi: 10.1002/acm2.12538. Epub 2019 Feb 20.

19.

An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer.

Bisello S, Renzulli M, Buwenge M, Calculli L, Sallustio G, Macchia G, Deodato F, Mattiucci G, Cammelli S, Arcelli A, Giaccherini L, Cellini F, Brandi G, Guerri S, Cilla S, Golfieri R, Fuccio L, Morganti AG, Guido A.

Oncol Lett. 2019 Feb;17(2):1784-1790. doi: 10.3892/ol.2018.9774. Epub 2018 Nov 28.

20.

Stereotactic body radiation therapy in cholangiocarcinoma: a systematic review.

Frakulli R, Buwenge M, Macchia G, Cammelli S, Deodato F, Cilla S, Cellini F, Mattiucci GC, Bisello S, Brandi G, Parisi S, Morganti AG.

Br J Radiol. 2019 May;92(1097):20180688. doi: 10.1259/bjr.20180688. Epub 2019 Feb 7.

PMID:
30673295
21.

Magnetic resonance imaging (MRI) compared with computed tomography (CT) for interobserver agreement of gross tumor volume delineation in pancreatic cancer: a multi-institutional contouring study on behalf of the AIRO group for gastrointestinal cancers.

Caravatta L, Cellini F, Simoni N, Rosa C, Niespolo RM, Lupattelli M, Picardi V, Macchia G, Sainato A, Mantello G, Dionisi F, Rosetto ME, Fusco V, Navarria F, De Paoli A, Guido A, Vecchi C, Basilico R, Cianci R, Delli Pizzi A, Di Nicola M, Mattiucci GC, Valentini V, Morganti AG, Genovesi D.

Acta Oncol. 2019 Apr;58(4):439-447. doi: 10.1080/0284186X.2018.1546899. Epub 2019 Jan 11.

PMID:
30632876
22.

Feasibility of 2D-conformal radiotherapy for pancreatic carcinoma.

Buwenge M, Cilla S, Cammelli S, Macchia G, Arcelli A, Farina E, Frakulli R, Panni V, Wondemagegnhu T, Uddin AFMK, Sumon MA, Deodato F, Morganti AG.

Oncol Lett. 2018 Nov;16(5):5939-5945. doi: 10.3892/ol.2018.9389. Epub 2018 Sep 4.

23.

Dose escalation in extracranial stereotactic ablative radiotherapy (DESTROY-1): A multiarm Phase I trial.

Deodato F, Macchia G, Cilla S, Ianiro A, Sallustio G, Cammelli S, Buwenge M, Mattiucci GC, Valentini V, Morganti AG.

Br J Radiol. 2019 Feb;92(1094):20180422. doi: 10.1259/bjr.20180422. Epub 2018 Nov 1.

24.

Hypofractionated radiotherapy after conservative surgery may increase low-intermediate grade late fibrosis in breast cancer patients.

Digesù C, Deodato F, Macchia G, Cilla S, Pieri M, Zamagni A, Farioli A, Buwenge M, Ferrandina G, Morganti AG.

Breast Cancer (Dove Med Press). 2018 Oct 3;10:143-151. doi: 10.2147/BCTT.S167914. eCollection 2018.

25.

Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief.

Buwenge M, Macchia G, Arcelli A, Frakulli R, Fuccio L, Guerri S, Grassi E, Cammelli S, Cellini F, Morganti AG.

J Pain Res. 2018 Oct 4;11:2169-2178. doi: 10.2147/JPR.S167994. eCollection 2018. Review.

26.

Radiotherapy in palliation of thoracic tumors: a phase I-II study (SHARON project).

Farina E, Macchia G, Buwenge M, Siepe G, Zamagni A, Cammelli S, Cilla S, Wondemagegnhu T, Woldemariam AA, Uddin AFMK, Sumon MA, Cellini F, Deodato F, Morganti AG.

Clin Exp Metastasis. 2018 Dec;35(8):739-746. doi: 10.1007/s10585-018-9942-6. Epub 2018 Oct 8.

PMID:
30298381
27.

Radiotherapy of pancreatic cancer in older patients: A systematic review.

Ciabatti S, Cammelli S, Frakulli R, Arcelli A, Macchia G, Deodato F, Cilla S, Giaccherini L, Buwenge M, Morganti AG.

J Geriatr Oncol. 2019 Jul;10(4):534-539. doi: 10.1016/j.jgo.2018.09.007. Epub 2018 Sep 28. Review.

PMID:
30270196
28.

Efficacy and safety of 3D-conformal half body irradiation in patients with multiple bone metastases.

Macchia G, Ferro M, Cilla S, Buwenge M, Ianiro A, Boccardi M, Picardi V, Ferro M, Arena E, Zamagni A, Cammelli S, Valentini V, Morganti AG, Deodato F.

Clin Exp Metastasis. 2018 Dec;35(8):747-752. doi: 10.1007/s10585-018-9939-1. Epub 2018 Sep 24.

PMID:
30251079
29.

EROS study: evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis.

Autorino R, Tagliaferri L, Campitelli M, Smaniotto D, Nardangeli A, Mattiucci GC, Macchia G, Gui B, Miccò M, Mascilini F, Ferrandina G, Kovacs G, Valentini V, Gambacorta MA.

J Contemp Brachytherapy. 2018 Aug;10(4):315-320. doi: 10.5114/jcb.2018.77953. Epub 2018 Aug 31.

30.

Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis.

Mattiucci GC, Morganti AG, Cellini F, Buwenge M, Casadei R, Farioli A, Alfieri S, Arcelli A, Bertini F, Calvo FA, Cammelli S, Fuccio L, Giaccherini L, Guido A, Herman JM, Macchia G, Maidment BW 3rd, Miller RC, Minni F, Regine WF, Reni M, Partelli S, Falconi M, Valentini V.

Transl Oncol. 2019 Jan;12(1):1-7. doi: 10.1016/j.tranon.2018.08.017. Epub 2018 Sep 17.

31.

Partially ablative radiotherapy (PAR) for large mass tumors using simultaneous integrated boost: A dose-escalation feasibility study.

Cilla S, Deodato F, Ianiro A, Macchia G, Picardi V, Buwenge M, Cammelli S, Zamagni A, Valentini V, Morganti AG.

J Appl Clin Med Phys. 2018 Nov;19(6):35-43. doi: 10.1002/acm2.12427. Epub 2018 Sep 15.

32.

Whole Lung Irradiation in Patients with Osteosarcoma and Ewing Sarcoma.

Ronchi L, Buwenge M, Cortesi A, Ammendolia I, Frakulli R, Abate ME, Arcelli A, Donati CM, Macchia G, Morganti AG, Cammelli S.

Anticancer Res. 2018 Sep;38(9):4977-4985. doi: 10.21873/anticanres.12816. Review.

PMID:
30194141
33.

Definitive Radiotherapy in Invasive Vaginal Carcinoma: A Systematic Review.

Guerri S, Perrone AM, Buwenge M, Ferioli M, Macchia G, Tagliaferri L, Ferrandina G, Galuppi A, Andrulli AD, Frakulli R, Cammelli S, Arcelli A, De Iaco P, Morganti AG.

Oncologist. 2019 Jan;24(1):132-141. doi: 10.1634/theoncologist.2017-0546. Epub 2018 Aug 23.

34.

Short-course regimen of palliative radiotherapy in complicated bone metastases: a phase i-ii study (SHARON Project).

Capuccini J, Macchia G, Farina E, Buwenge M, Genovesi D, Caravatta L, Nguyen NP, Cammelli S, Cilla S, Wondemagegnhu T, Uddin AFMK, Aziz Sumon M, Cellini F, Valentini V, Deodato F, Morganti AG.

Clin Exp Metastasis. 2018 Oct;35(7):605-611. doi: 10.1007/s10585-018-9931-9. Epub 2018 Aug 18.

PMID:
30121938
35.

Brachytherapy boost after chemoradiation in anal cancer: a systematic review.

Frakulli R, Buwenge M, Cammelli S, Macchia G, Farina E, Arcelli A, Ferioli M, Fuccio L, Tagliaferri L, Galuppi A, Frezza GP, Morganti AG.

J Contemp Brachytherapy. 2018 Jun;10(3):246-253. doi: 10.5114/jcb.2018.76884. Epub 2018 Jun 29. Review.

36.

Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial.

Mantini G, Siepe G, Alitto AR, Buwenge M, Nguyen NP, Farioli A, Schiavina R, Catucci F, Deodato F, Fionda B, Frascino V, Macchia G, Ntreta M, Padula GDA, Arcelli A, Cammelli S, Rambaldi GZ, Cilla S, Valentini V, Morganti AG.

Prostate Cancer Prostatic Dis. 2018 Nov;21(4):564-572. doi: 10.1038/s41391-018-0064-7. Epub 2018 Jul 23.

37.

Definition of fields margins for palliative radiotherapy of pancreatic carcinoma.

Buwenge M, Marinelli A, Deodato F, Macchia G, Wondemagegnhu T, Salah T, Cammelli S, Uddin AFMK, Sumon MA, Donati CM, Cilla S, Morganti AG.

Mol Clin Oncol. 2018 Jun;8(6):715-718. doi: 10.3892/mco.2018.1605. Epub 2018 Apr 12.

38.

Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.

Ferrandina G, Palluzzi E, Gallotta V, Gambacorta MA, Autorino R, Turco LC, Macchia G, Cosentino F, Gui B, Mattoli MV, Ronzino G, Valentini V, Scambia G.

Eur J Surg Oncol. 2018 Jul;44(7):1062-1068. doi: 10.1016/j.ejso.2018.04.019. Epub 2018 May 3.

PMID:
29753611
39.

Phase I-II Study of Short-course Accelerated Radiotherapy (SHARON) for Palliation in Head and Neck Cancer.

Farina E, Capuccini J, Macchia G, Caravatta L, Nguyen NP, Cammelli S, Farioli A, Zanirato Rambaldi G, Cilla S, Wondemagegnhu T, Uddin AFMK, Sumon MA, Genovesi D, Buwenge M, Cellini F, Valentini V, Deodato F, Morganti AG.

Anticancer Res. 2018 Apr;38(4):2409-2414.

PMID:
29599369
40.

Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients.

Macchia G, Gambacorta MA, Masciocchi C, Chiloiro G, Mantello G, di Benedetto M, Lupattelli M, Palazzari E, Belgioia L, Bacigalupo A, Sainato A, Montrone S, Turri L, Caroli A, De Paoli A, Matrone F, Capirci C, Montesi G, Niespolo RM, Osti MF, Caravatta L, Galardi A, Genovesi D, Rosetto ME, Boso C, Sciacero P, Giaccherini L, Parisi S, Fontana A, Filippone FR, Picardi V, Morganti AG, Valentini V.

Clin Transl Radiat Oncol. 2017 May 17;4:8-14. doi: 10.1016/j.ctro.2017.04.004. eCollection 2017 Jun.

41.

The Role of Radiotherapy in Extramammary Paget Disease: A Systematic Review.

Tagliaferri L, Casà C, Macchia G, Pesce A, Garganese G, Gui B, Perotti G, Gentileschi S, Inzani F, Autorino R, Cammelli S, Morganti AG, Valentini V, Gambacorta MA.

Int J Gynecol Cancer. 2018 May;28(4):829-839. doi: 10.1097/IGC.0000000000001237.

PMID:
29538255
42.

Postoperative Hypofractionated Radiation Therapy in Prostate Carcinoma: A Systematic Review.

Siepe G, Buwenge M, Nguyen NP, Macchia G, Deodato F, Cilla S, Mattiucci GC, Capocaccia I, Cammelli S, Guido A, Arcelli A, Ntreta M, Guerri S, Morganti AG.

Anticancer Res. 2018 Mar;38(3):1221-1230. Review.

PMID:
29491044
43.

Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis.

Farina E, Capuccini J, Macchia G, Caravatta L, Nguyen NP, Cammelli S, Zanirato Rambaldi G, Cilla S, Wondemagegnhu T, Uddin AFMK, Sumon MA, Genovesi D, Buwenge M, Cellini F, Valentini V, Deodato F, Morganti AG.

J Geriatr Oncol. 2018 Jul;9(4):359-361. doi: 10.1016/j.jgo.2018.01.004. Epub 2018 Feb 15.

PMID:
29398455
44.

Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.

Cima S, Perrone AM, Castellucci P, Macchia G, Buwenge M, Cammelli S, Cilla S, Ferioli M, Ferrandina G, Galuppi A, Salizzoni E, Rubino D, Fanti S, De Iaco P, Morganti AG.

Int J Gynecol Cancer. 2018 Mar;28(3):575-580. doi: 10.1097/IGC.0000000000001207.

PMID:
29372911
45.

The Hidden Genomic and Transcriptomic Plasticity of Giant Marker Chromosomes in Cancer.

Macchia G, Severgnini M, Purgato S, Tolomeo D, Casciaro H, Cifola I, L'Abbate A, Loverro A, Palumbo O, Carella M, Bianchini L, Perini G, De Bellis G, Mertens F, Rocchi M, Storlazzi CT.

Genetics. 2018 Mar;208(3):951-961. doi: 10.1534/genetics.117.300552. Epub 2017 Dec 26.

46.

18F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study.

Farina E, Monari F, Castellucci P, Romani F, Repaci A, Farina A, Zanirato Rambaldi G, Frezza G, Mazzarotto R, Cammelli S, Tagliaferri L, Autorino R, Deodato F, Macchia G, Cilla S, Valentini V, Fanti S, Morganti AG.

J Thyroid Res. 2017;2017:9807543. doi: 10.1155/2017/9807543. Epub 2017 Oct 19.

47.

Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: a Pareto front analysis for liver metastases.

Cilla S, Ianiro A, Deodato F, Macchia G, Digesù C, Valentini V, Morganti AG.

Med Dosim. 2018 Autumn;43(3):291-301. doi: 10.1016/j.meddos.2017.10.006. Epub 2017 Nov 27.

PMID:
29191470
48.

[A case of pulmonary artery sarcoma and review of the literature].

Todaro MC, Orlassino R, Fornengo C, Ravera A, Macchia G, Soffiantino F, Lovato RL, Senatore G.

G Ital Cardiol (Rome). 2017 Nov;18(11):792-795. doi: 10.1714/2803.28366. Review. Italian.

PMID:
29105675
49.

Hypofractionated Postoperative IMRT in Prostate Carcinoma: A Phase I/II Study.

Macchia G, Siepe G, Capocaccia I, Nguyen NP, Schiavina R, Cammelli S, Guerri S, Arcelli A, Buwenge M, Ntreta M, Cilla S, Valentini V, Deodato F, Morganti AG.

Anticancer Res. 2017 Oct;37(10):5821-5828.

PMID:
28982907
50.

Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer.

Ippolito E, Guido A, Macchia G, Deodato F, Giaccherini L, Farioli A, Arcelli A, Cuicchi D, Frazzoni L, Cilla S, Buwenge M, Mantini G, Alitto AR, Nuzzo M, Valentini V, Ingrosso M, Morganti AG, Fuccio L.

In Vivo. 2017 Sep-Oct;31(5):961-966.

Supplemental Content

Loading ...
Support Center